Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: J Mol Cell Cardiol. 2018 Nov 28;127:20–30. doi: 10.1016/j.yjmcc.2018.11.017

Figure 5. Changes in the expression of the molecular correlates of myocardial conduction.

Figure 5.

A. mRNA expression of fibrosis markers Col1A1 (N=5 CTRL, 4 MCT, 7 MCT+S2a), Col1A2 (N= 5 CTRL, 4 MCT, 5 MCT+S2a), and Col3A1 (N= 4 CTRL, 4 MCT, 7 MCT+S2a), measured by RT-PCR in CTRL, MCT, and MCT+S2a hearts. B. mRNA expression of myosin heavy chain α (MHC-α) (N= 4 CTRL, 4 MCT, 7 MCT+S2a), atrial natriuretic peptide (ANP) (N= 4 CTRL, 4 MCT, 7 MCT+Sa), and brain natriuretic peptide (BNP) (N= 6 CTRL, 6 MCT, 7 MCT+S2a). C. mRNA expression of the pore-forming L- and T-type calcium channels, Cav1.2 and Cav3.1 in CTRL, MCT, and MCT+S2a RV samples. *P <0.05, **P <0.005, ***P <0.0005 by one-way ANOVA and Tukey post-test.